Total Payments
$4,394
2024 Payments
$904.70
Companies
26
Transactions
210
Medicare Patients
1,770
Medicare Billing
$355,252
Payment Breakdown by Category
Food & Beverage$4,394 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,394 | 210 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $724.22 | 28 | $0 (2024) |
| GENZYME CORPORATION | $707.56 | 30 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $519.17 | 29 | $0 (2024) |
| CSL Behring | $309.67 | 15 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $298.58 | 20 | $0 (2024) |
| kaleo, Inc. | $281.40 | 15 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $251.53 | 13 | $0 (2023) |
| Optinose US, Inc. | $217.47 | 11 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $204.17 | 10 | $0 (2024) |
| Shire North American Group Inc | $153.79 | 8 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $904.70 | 36 | GENZYME CORPORATION ($243.37) |
| 2023 | $847.92 | 37 | GlaxoSmithKline, LLC. ($252.56) |
| 2022 | $488.40 | 22 | GlaxoSmithKline, LLC. ($167.71) |
| 2021 | $632.05 | 35 | AstraZeneca Pharmaceuticals LP ($116.39) |
| 2020 | $537.67 | 29 | GENZYME CORPORATION ($116.64) |
| 2019 | $481.34 | 27 | Shire North American Group Inc ($139.43) |
| 2018 | $320.92 | 18 | GlaxoSmithKline, LLC. ($87.46) |
| 2017 | $180.59 | 6 | Intersect ENT, Inc. ($89.25) |
All Payment Transactions
210 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 12/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.01 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 10/29/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: Immunology | ||||||
| 10/15/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 10/08/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Immunology | ||||||
| 09/24/2024 | Neurent Medical Limited | NEUROMARK Device (Device), NEUROMARK Radiofrequency Console | Food and Beverage | Cash or cash equivalent | $30.88 | General |
| Category: Electrosurgical, Cutting & Coagulation & Accessories | ||||||
| 09/12/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $24.51 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 09/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.40 | General |
| Category: Immunology | ||||||
| 08/15/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $27.78 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 07/30/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: Immunology | ||||||
| 07/23/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 07/11/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/26/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $29.23 | General |
| Category: Immunology | ||||||
| 06/13/2024 | kaleo, Inc. | AUVI-Q (Drug) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Allergy | ||||||
| 06/04/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Immunology | ||||||
| 05/23/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $26.66 | General |
| Category: Immunology | ||||||
| 05/20/2024 | Hikma Pharmaceuticals USA | Ryaltris (Drug) | Food and Beverage | In-kind items and services | $50.50 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 05/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $34.41 | General |
| Category: Immunology | ||||||
| 05/06/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $30.72 | General |
| Category: IMMUNOLOGY | ||||||
| 04/29/2024 | Grifols USA, LLC | Xembify (Biological) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: Immunology and Neurology | ||||||
| 04/23/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: Immunology | ||||||
| 04/09/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $32.76 | General |
| Category: Immunology | ||||||
| 04/03/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $28.81 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 04/02/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 624 | 976 | $541,978 | $125,361 |
| 2022 | 9 | 513 | 772 | $457,614 | $105,263 |
| 2021 | 6 | 356 | 558 | $228,291 | $69,676 |
| 2020 | 5 | 277 | 474 | $151,484 | $54,951 |
Total Patients
1,770
Total Services
2,780
Medicare Billing
$355,252
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2023 | 162 | 285 | $218,310 | $50,224 | 23.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 176 | 340 | $73,780 | $28,720 | 38.9% |
| 31237 | Biopsy or removal of nasal polyp or tissue using an endoscope | Office | 2023 | 20 | 63 | $180,504 | $20,994 | 11.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 70 | 70 | $14,000 | $6,781 | 48.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 43 | 48 | $10,800 | $5,683 | 52.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 20 | 22 | $7,722 | $3,719 | 48.2% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 68 | 79 | $22,499 | $3,054 | 13.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $5,400 | $2,379 | 44.1% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2023 | 14 | 17 | $4,930 | $2,123 | 43.1% |
| G0268 | Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | Office | 2023 | 36 | 37 | $4,033 | $1,684 | 41.8% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2022 | 125 | 215 | $164,690 | $40,075 | 24.3% |
| 31237 | Biopsy or removal of nasal polyp or tissue using an endoscope | Office | 2022 | 22 | 74 | $183,816 | $23,804 | 12.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 159 | 251 | $54,467 | $20,999 | 38.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 60 | 60 | $12,000 | $6,125 | 51.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 30 | 40 | $9,000 | $4,867 | 54.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 17 | 20 | $7,020 | $3,323 | 47.3% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 59 | 70 | $19,328 | $2,799 | 14.5% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2022 | 14 | 15 | $4,350 | $1,971 | 45.3% |
| G0268 | Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | Office | 2022 | 27 | 27 | $2,943 | $1,300 | 44.2% |
| 31231 | Diagnostic examination of nasal passages using an endoscope | Office | 2021 | 102 | 178 | $114,931 | $34,453 | 30.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 132 | 230 | $43,747 | $19,036 | 43.5% |
| 31237 | Biopsy or removal of nasal polyp or tissue using an endoscope | Office | 2021 | 11 | 21 | $40,308 | $6,946 | 17.2% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 48 | 48 | $9,600 | $4,350 | 45.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 18 | 21 | $4,725 | $2,538 | 53.7% |
| 69210 | Removal of impact ear wax, one ear | Office | 2021 | 45 | 60 | $14,980 | $2,354 | 15.7% |
About Dr. Alexis Jackman, MD
Dr. Alexis Jackman, MD is a Otolaryngology healthcare provider based in Purchase, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1245247311.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alexis Jackman, MD has received a total of $4,394 in payments from pharmaceutical and medical device companies, with $904.70 received in 2024. These payments were reported across 210 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($4,394).
As a Medicare-enrolled provider, Jackman has provided services to 1,770 Medicare beneficiaries, totaling 2,780 services with total Medicare billing of $355,252. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Otolaryngology
- Other Specialties Otolaryngology
- Location Purchase, NY
- Active Since 08/02/2006
- Last Updated 04/02/2019
- Taxonomy Code 207Y00000X
- Entity Type Individual
- NPI Number 1245247311
Products in Payments
- DUPIXENT (Biological) $981.96
- NUCALA (Biological) $699.51
- CUVITRU (Biological) $314.54
- Hizentra (Biological) $309.67
- AUVI-Q (Drug) $281.40
- XOLAIR (Drug) $269.50
- XOLAIR (Biological) $249.67
- Xhance (Drug) $217.47
- FASENRA (Biological) $212.73
- PROPEL (Device) $139.60
- Xolair (Biological) $110.43
- Otovel (Drug) $93.30
- Xembify (Biological) $82.09
- Ryaltris (Drug) $50.50
- HYQVIA (Biological) $43.42
- Dymista (Drug) $39.72
- FASENRA (Drug) $38.80
- NEUROMARK Device (Device) $30.88
- AYVAKIT (Drug) $29.76
- ProAir Digihaler (Drug) $25.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.